# A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic Rhinosinusitis With Nasal Polyps

> **NCT07755371** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Akeso** · enrollment: 75 (estimated)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

## Interventions

- **BIOLOGICAL:** AK139
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT07755371
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-10
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-07-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07755371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07755371, "A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic Rhinosinusitis With Nasal Polyps". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07755371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*